Insider Transactions Reported by 9 Insiders of Silence Therapeutics plc

Symbol
SLN on Nasdaq, SLNCF on OTC
Location
London

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

Silence Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael H. Davidson Director 02 Jan 2025
James Ede-Golightly Director 02 Jan 2026
Steven J. Romano EVP and Chief R&D Officer 02 Jan 2026
CRAIG A. TOOMAN President and CEO, Director 02 Jan 2025
David Lemus Director 02 Jan 2026
Iain Ross Interim PEO, Director 18 Dec 2025
Rhonda Hellums Chief Financial Officer, Director 02 Jan 2026
Richard Ian Griffiths 10%+ Owner 31 Jul 2025
TIMOTHY MCINERNEY Director 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for Silence Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.